Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2003
12/24/2003CN1462618A Fibrauretine in dosage form of decentralization tablet
12/24/2003CN1462616A Method of preparing medical use injection containing high oxygen
12/24/2003CN1131713C Externally-applied medicine for treating nasosinusitis
12/24/2003CA2779633A1 Combination of azelastine and steroids
12/24/2003CA2779630A1 Combination of azelastine and steroids
12/24/2003CA2491846A1 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
12/24/2003CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
12/24/2003CA2489458A1 Substituted diaminopyrimidines
12/24/2003CA2489249A1 Carboxamides derivatives
12/24/2003CA2489106A1 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
12/24/2003CA2488879A1 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
12/24/2003CA2488026A1 Powdery respiratory tonic composition
12/24/2003CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003CA2479309A1 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
12/23/2003US6667393 Azalide antibiotic compositions
12/23/2003US6667344 Formoterol, or a derivative; long term storage stability
12/23/2003US6667334 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/23/2003US6667325 P38MAP kinase inhibiters; tumor necrosis factor alpha, interleukin 1 and 6 and cyclooxygenase II related diseases
12/23/2003US6667320 For therapy of infalmmation; asthma, cancer, arthritis, multiple sclerosis; prophylaxis of infection of target cells by a human immunodeficiency virus (HIV)
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667316 Pharmaceutically active isoindoline derivatives
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003US6667300 Purinyl substituted quinazoline-4-one derivatives
12/18/2003WO2003104807A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003WO2003104280A1 Anti-pharyngolaryngitis composition with igy and its agent
12/18/2003WO2003104255A2 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104230A1 Bicyclic pyrimidine derivatives
12/18/2003WO2003104228A1 Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
12/18/2003WO2003104223A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors
12/18/2003WO2003104219A1 Nf-kb inhibitors
12/18/2003WO2003104218A1 Nf-:b inhibitors
12/18/2003WO2003104205A1 Aryloximes
12/18/2003WO2003104204A1 Pyridazine derivatives
12/18/2003WO2003104203A1 Therapeutic molecules and methods-1
12/18/2003WO2003104198A1 Chemokine receptor antagonist
12/18/2003WO2003104197A1 Polymorphic form xvi of fexofenadine hydrochloride
12/18/2003WO2003104195A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor
12/18/2003WO2003103702A1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
12/18/2003WO2003103695A1 Novel therapeutic use of polypodium extracts
12/18/2003WO2003103682A1 Compositions for cancer therapy saponins or sapogenins
12/18/2003WO2003103675A2 Combination treatments for purinoceptor-related disorders
12/18/2003WO2003103671A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/18/2003WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
12/18/2003WO2003103665A1 Antiallergic
12/18/2003WO2003103663A2 Substituted pyrrolines as kinase inhibitors
12/18/2003WO2003103661A1 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/18/2003WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof
12/18/2003WO2003103590A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003WO2003103577A2 Novel recombinant anticoagulant proteins
12/18/2003WO2003097052A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
12/18/2003WO2003087087A3 Heterocyclic compounds and their use as modulators of p38 map kinase
12/18/2003WO2003066593A3 Preparation of pharmaceutical salts of 4 ( (z) - (4-bromophenyl) (ethoxyimino) methyl )-1'-( (2,4-dimethyl-1-oxido-3-pyridinyl) carbonyl) -4'-methyl-1,4' bipiperidine as ccr5-antagonists for the treatment of aids and related hiv infections
12/18/2003WO2003057149A3 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones
12/18/2003WO2003050108A8 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
12/18/2003WO2003049599A3 Methods and compositions for the diagnosis of asthma
12/18/2003WO2003045363A3 Treatment of th2 dominated immunological disease states with progesterone receptor antagonists
12/18/2003WO2003044021A3 Substituted indolizine-like compounds and methods of use
12/18/2003WO2003029437A3 Secreted proteins
12/18/2003WO2003028712A3 Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases
12/18/2003WO2003027234A3 Small organic molecule regulators of cell proliferation
12/18/2003WO2003013536A3 Methods for treatment of cancer using irinotecan based on ugt1a1
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2002100899A3 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/18/2003WO2002081668A3 Desaturase genes and uses thereof
12/18/2003WO2002078618A3 Methods of modulating surfactant production
12/18/2003WO2002058723A3 Chemokines as adjuvants of immune response
12/18/2003WO2002038561A8 Indolylmaleimide derivatives as protein kinase c inhibitors
12/18/2003WO2002032435A9 A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
12/18/2003WO2002017878A8 Lung surfactant compositions with dynamic swelling behaviour
12/18/2003US20030232993 Process for preparing scopine esters
12/18/2003US20030232868 Cyclic carboxylic acids as integrin antagonists
12/18/2003US20030232865 1,4-Benzofused urea compounds useful in treating cytokine mediated diseases
12/18/2003US20030232864 Novel Compounds and compositions as protease inhibitors
12/18/2003US20030232859 Antiinflammatory agents; for treatment of rheumatoid arthritis and multiple sclerosis
12/18/2003US20030232855 Such as N-(benzo(1,3)dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2 -dihydroquinoline-3-carboxamide for stimulation of peripheral cell type cannabinoid receptors
12/18/2003US20030232849 N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/18/2003US20030232848 Pyrazole compositions
12/18/2003US20030232847 Imidazo-substituted compounds as p38 kinase inhibitors
12/18/2003US20030232846 Caspase inhibitors and uses thereof
12/18/2003US20030232845 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects
12/18/2003US20030232838 6-phenylpyrrolopyrimidinedione derivatives
12/18/2003US20030232831 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
12/18/2003US20030232823 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations, and uses thereof
12/18/2003US20030232813 Novel amino substituted pyrimidinone derivatives
12/18/2003US20030232802 Aryl and heteroaryl sulfonates
12/18/2003US20030232791 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
12/18/2003US20030232763 Reducing blood glucose concentrations, weight loss, and treating diseases and conditions mediated by the cyclooxygenase-2 and 5-lipoxygenase enzymes; an enzyme inhibitors
12/18/2003US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders
12/18/2003US20030232326 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
12/18/2003US20030232083 Modified release dosage form
12/18/2003US20030232082 Modified release dosage forms
12/18/2003US20030232048 Methods for treating chronic obstructive pulmonary disease (COPD)
12/18/2003DE10215316C1 Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer Quinoline and isoquinoline derivatives, to a pharmaceutical agent and their use as anti-inflammatory agents
12/18/2003CA2488798A1 Substituted pyrrolines as kinase inhibitors